PMA device
Wavelight Allegretto Wave Excimer Laser System
Alcon Laboratories, Inc. · Excimer Laser System (LZS, Class III) · First FDA decision Oct 7, 2003, newest Feb 21, 2013Nearsightedness and refractive error
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
5
Naming "Wavelight Allegretto Wave"
MAUDE reports
0
Brand "Wavelight Allegretto Wave", since 2015
PubMed studies
27
Mentioning "Wavelight Allegretto Wave"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Wavelight Allegretto Wave Excimer Laser System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 9 decisions filed under this name.
FDA's records could not be loaded.
Older decisions: P020050-S004, P020050-S001, P020050
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Wavelight Allegretto Wave", any status and sponsor, newest update first.
- Analysis of I-Trace High Order Aberrations Induced by Wavefront Optimized Ablation ProfilesCompleted
Alexandria UniversityAcademic, hospital or other
NCT04452448 · 10 participants · Start Jan 10, 2018 · Primary completion May 30, 2020
Device: LASIK · For: Myopia
Sites: Alexandria, Egypt
- A Safety and Effectiveness Study of PRK Using the ALLEGRETTO WAVE® EYE-Q Excimer Laser SystemCompleted
Alcon ResearchNot on our public-company list
NCT01699087 · 176 participants · Start Aug 2012 · Primary completion Jul 2015
Device: ALLEGRETTO WAVE EYE-Q excimer laser system · For: Myopia; Astigmatism
Durrie VisionAcademic, hospital or other
NCT00821236 · 40 participants · Start Jan 2009 · Primary completion Feb 2010
Device: Excimer Laser; AMO/VISX CustomVue™ and 1 more · For: Myopia; Astigmatism
Sites: Overland Park, Kansas; Greensboro, North Carolina
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Wavelight Allegretto Wave", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LZS
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Wavelight Allegretto Wave"[tiab]. The summary above synthesizes these.
- Transitioning to optimized correction with the WaveLight ALLEGRETTO WAVE: case distribution, visual outcomes, and wavefront aberrations.
George MR, Shah RA, Hood C, et al. · J Refract Surg · 2010
- Prospective, randomized, fellow eye comparison of WaveLight Allegretto Wave Eye-Q versus VISX CustomVueTM STAR S4 IRTM in photorefractive keratectomy: analysis of visual outcomes and higher-order aberrations.
Moshirfar M, Churgin DS, Betts BS, et al. · Clin Ophthalmol · 2011
- Visual and refractive outcomes of LASIK with the SCHWIND ESIRIS and WaveLight ALLEGRETTO WAVE Eye-q excimer lasers: a prospective, contralateral study.
Mearza AA, Muhtaseb M, Aslanides IM · J Refract Surg · 2008Comparative Study
- Wavefront-guided enhancements using the wavelight excimer laser in symptomatic eyes previously treated with LASIK.
Kanellopoulos AJ, Pe LH · J Refract Surg · 2006Comparative Study
- Subjective Quality of Vision After Myopic LASIK: Prospective 1-Year Comparison of Two Wavefront-Guided Excimer Lasers.
Yu CQ, Manche EE · J Refract Surg · 2016Comparative Study, Randomized Controlled Trial
- Comparison of outcomes of conventional WaveLight(®) Allegretto Wave(®) and Technolas(®) excimer lasers in myopic laser in situ keratomileusis.
Han DC, Chen J, Htoon HM, et al. · Clin Ophthalmol · 2012Case Reports
- Photorefractive keratectomy for myopia and myopic astigmatism correction using the WaveLight Allegretto Wave Eye-Q excimer laser system.
Costa E, Franqueira N, Rosa AM, et al. · Int Ophthalmol · 2014
- A prospective, randomized, fellow eye comparison of WaveLight® Allegretto Wave ® Eye-Q versus VISX CustomVueࡊ STAR S4 IRࡊ in laser in situ keratomileusis (LASIK): analysis of visual outcomes and higher order aberrations.
Moshirfar M, Betts BS, Churgin DS, et al. · Clin Ophthalmol · 2011
- Quality of life and satisfaction among physicians after wavefront-optimized vs topography-guided laser vision correction.
Ma J, Pillar A, Krueger R · J Cataract Refract Surg · 2020
- Quality of Vision After Wavefront-Guided or Wavefront-Optimized LASIK: A Prospective Randomized Contralateral Eye Study.
Kung JS, Manche EE · J Refract Surg · 2016Comparative Study, Randomized Controlled Trial
- Optimized femto-LASIK maintains preexisting spherical aberration independent of refractive error.
Au JD, Krueger RR · J Refract Surg · 2012
- Wavefront-optimized versus wavefront-guided LASIK for myopic astigmatism with the ALLEGRETTO WAVE: three-month results of a prospective FDA trial.
Stonecipher KG, Kezirian GM · J Refract Surg · 2008Comparative Study, Multicenter Study
Other devices of this type
Also filed under product code LZS.
- WaveLight EX500 LaserAlcon Laboratories, Inc. · PMA 2025
- STAR S4 IR Excimer Laser System and iDESIGN Refractive StudioAmo Manufacturing USA, LLC · PMA 2019
- Nidek EC-5000 Excimer Laser SystemNidek Co., Ltd. · PMA 2018
- Bausch & Lomb Technolas T217Z Zyoptix Laser SystemTechnolas Perfect Vision GmbH · PMA 2010
- Ladarvision 4000 Excimer Laser System and the Ladar 6000 Excimer Laser SystemAlcon Laboratories · PMA 2006
- Allegretto Wave Eye-Q Excimer Laser SystemAlcon Laboratories, Inc. · PMA 2015
- Technolas 217A Excimer Laser SystemTechnolas Perfect Vision GmbH · PMA 2003
- iDESIGN Refractive Studio, STAR S4 IR Excimer Laser SystemAmo Manufacturing USA, LLC · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.